Muscarinic ciliostimulation requires endogenous prostaglandin production

American Journal of Rhinology

Volumn 12, Issue 3, 1998, Pages 203-207

  Gayner, Scott M ^a   McCaffrey, Thomas V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; METHACHOLINE; MUSCARINIC RECEPTOR; PACOCF3; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPASE C; PROSTAGLANDIN; PROSTAGLANDIN E2; TERBUTALINE; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; UNCLASSIFIED DRUG;

ADENOID; ARTICLE; CILIARY MOTILITY; DRUG EFFECT; ENZYME INHIBITION; EXPLANT; HUMAN; HUMAN TISSUE; MUCOCILIARY TRANSPORT; PROTEIN DETERMINATION; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION; TISSUE PREPARATION;

EID: 0031850105     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065898781390190     Document Type: Article

References (19)

1. Hybbinette JC, Mercke U. Effects of the parasympathetic drug methacholine and its antagonist atropine on mucociliary activity. Acta Otolaryngol (Stockh) 93:465-473, 1982.
2. Devalia JL, Davies RJ. Human nasal and bronchial epithelial cells in culture: An overview of their characteristics and function. Allergy Proc 12:71-79, 1991.
3. Brown MS, Peters SP, Adkinson NF, et al. Arachidonic acid metabolites during nasal challenge. Arch Otolaryngol Head Neck Surg 113:179-183, 1987.
4. Ohashi Y, Nakai Y, Kihara S, et al. Ciliary activity in patients with nasal allergies. Arch Otorhinolaryngol 242:141-147, 1985.
5. Holtzman MJ. Arachidonic acid metabolism in airway epithelial cells. Annu Rev Physiol 54:303-329, 1977.
6. Bonin SR, Phillips PP, McCaffrey TV. The effect of arachidonic acid metabolites on the ciliary beat frequency of human nasal mucosa in vitro. Acta Otolaryngol (Stockh) 112:697-702, 1992.
7. 2 on ciliary beat frequency of human upper respiratory cilia in vitro. Acta Otolaryngol (Stockh) 115:438-442, 1995.
8. Yang B, Schlosser RJ, McCaffrey TV. Dual signal transduction mechanisms modulate ciliary beat frequency in upper airway epithelium. Am J Physiol 270:L745-L751, 1996.
9. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951.
10. Buccafusco JJ, Lapp CA, Aronstam RS, et al. Role of prostanoids in the regulation of central cholinergic receptor sensitivity. J Pharmacol Exp Ther 266:314-322, 1993.
11. Yang BC, Nichols WW, Mehta JL. Cardiac effects of acetylcholine in rat hearts: Role of endothelium-derived relaxing factor and prostaglandins. Am J Physiol 264:1388-1393, 1993.
12. Azadzoi KM, Kim N, Brown ML, et al. Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone. J Urol 147:220-225, 1992.
13. Humle EC, Birdsall NJM, Muckley NJ. Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 30:633-673, 1990.
14. Wess J. Mutational analysis of muscarinic acetylcholine receptors: structural basis of ligand/receptor/G protein interactions. Life Science 53:1447-1463, 1993.
15. Lambert DG. Signal transduction: G protein and second messengers. Br J Anaes 72:86-95, 1993.
16. 3 muscarinic antagonists inhibit human nasal glandular secretion in vitro. J Appl Physiol 73:2069-2073, 1992.
17. Baraniuk JN, Lundgren JD, Okayama M, et al.;. Vasoactive intestinal peptide in human nasal mucosa. J Clin Invest 86:825-831, 1990.
18. Tomlinson S, MacNeil S, Brown BL. Calcium, cyclic AMP and hormone action. Clin Endocrinol 23:595-610, 1985.
19. Salvemini D, Misko TP, Masferrer JL, et al. Nitric oxide activates cyclooxygenase enzymes. Pharmacol 90:7240-7244, 1993.